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Abstract
Objectives: We aimed to evaluate the changes over time in the prevalence, awareness, treatment, and control rate
of hypertension in intervention and reference areas of a comprehensive community trial with reference area.
Methods: Data from independent sample surveys before and after implementation of the program (2001 vs.2007)
were used to compare differences in the intervention and references areas over time. Hypertension was defined as
blood pressure ≥140/90 mmHg in non-diabetic patients and ≥130/80 mmHg in diabetic individuals and or taking
antihypertensive medications. Interventional activities included educational strategies at population level as well as
for hypertensive patients, their families and health professionals.
Results: The study population of the baseline survey included 6175 (48.7% males) in the interventional area and
6339 (51.3% male) in the reference area. The corresponding figures in the post-intervention phase was 4717 (49.3%
male) in the interventional area and 4853 (50.7% male) individuals in the reference area. The prevalence of
hypertension had a non-significant decrease from 20.5%to 19.6%, in the interventional area whereas in the
reference area, it increased from 17.4% to 19.6% (P = 0.003). If we consider Bp ≥ 140/90 in diabetic and non-
diabetic patients as hypertension definition, the prevalence of hypertension in the interventional areas had a non-
significant decrease from 18.9% in 2001 to 17.8% in 2007, whereas in the reference area, it had a significant rise
from 15.7% to 17.9% (P = 0.002) respectively. Awareness, treatment and control rates of hypertension had better
improvement in urban and rural part of the interventional area compared to reference area. The awareness,
treatment, and control rates of hypertension increased significantly in the age groups of more than 40 years, as
well as in all groups of body mass index in interventional areas without significant change in the reference area.
Mean systolic blood pressure of study population in the interventional area decreased from 116.13 ±19.37 to
112.92 ± 18.27 mmHg (P < 0.001) without significant change in reference area.
Conclusions: This comprehensive and integrated program of interventions was effective in tackling with the
prevalence of hypertension, and may improve the awareness, treatment and control rates of this disorder in a
developing country setting.
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Hypertension is a major and common risk factor for
premature disability and death [1-3]. It is a leading
cause of stroke, congestive heart failure, and other cardi-
ovascular diseases in Western [4-6] and Asian [7] popu-
lations. Its control is necessary for the prevention of
related adverse effects [8]. Some studies have shown
poor awareness and control of hypertension in different
populations including Iranian populations. This undesir-
able level of hypertension control may provide a promis-
ing area for aggressive intervention [9].
Previous studies in Iranian population showed that
despite improvement in the awareness, treatment and
control rate of hypertension the situation is not desir-
able[9,10]. As a public health response to the escalating
trend of chronic non-communicable diseases (NCDs) in
Iran, Isfahan Healthy Heart Program (IHHP) was con-
ducted as a comprehensive healthy lifestyle community
trial for NCDs prevention and health promotion [10,11].
Its interventions were conducted in two provincial
counties of Isfahan and Najaf-Abad and were compared
with Arak as reference area. One of the objectives of
this program was to increase the awareness, treatment
and control rates of hypertension [11].
Given the awareness, treatment and control rates of
hypertension are low in Iranians [9] it seems that low
community awareness and lack of physician training are
important. Therefore, IHHP aimed to increase the
awareness rate of community and to improve the level
of treatment among hypertensive individuals. Increasing
the level of health professional’s knowledge and treat-
ment skills about hypertension were another goals in
this program. This paper presents the results of the 6-
years interventions of IHHP on the prevalence of hyper-
tension as well as the changes of hypertension aware-
ness, treatment, and control in the population of the
interventional areas in comparison with the reference
area. It also reports these differences based on area of
residence, age groups and body mass index (BMI).
Methods
IHHP was conducted as a community-based program
for promoting healthy lifestyle behaviors, and ultimately
to prevent NCDs in a developing country setting. It
integrates interventions and policies that target the
major determinants of NCDs including unhealthy nutri-
tion, smoking, physical inactivity and stress [10,11].
Ethics committee of Isfahan Cardiovascular Research
Center, a collaborating center of the World Health
Organization, and affiliated to Isfahan University of
Medical Sciences and other relevant national regulatory
organizations approved this study. Written informed
consent was obtained from participants after full expla-
nation of the study protocol. In 2000-2001, the baseline
survey was conducted in three counties. Two provincial
counties of Isfahan and Najaf-Abad with populations of
1,895,856 and 275,084, respectively, were considered as
venues of intervention; and Arak, a provincial county
located 375 km northwest of Isfahan with a population
of 668,531, as the reference area because of socioeco-
nomic, demographic, health profile similarities to the
intervention areas. The populations of the three counties
were studied for cardiovascular disease (CVD) related
risk behaviors and risk factors.
After the baseline survey in 2000, from 2001 interven-
tions were conducted in the intervention communities,
and Arak was monitored for comparative purposes; rou-
tine national health activities were continuing in both
intervention and reference areas. IHHP was developed
as an action-oriented, quasi-experimental demonstration
program with simultaneous evaluation and different
research studies. Its interventions were conducted
through 10 projects with different target groups (Addi-
tional file 1). Behavioral variables were determined
through annual questionnaire-based surveys on indepen-
dent samples in intervention and reference commu-
nities. Then, in 2007 the whole baseline survey was
repeated on an independent random sample of both
communities. Individuals were selected using multistage
random sampling and were invited to the survey centers
for interview, clinical examination and blood sampling.
A standardized questionnaire was used to obtain infor-
mation on demographic and socioeconomic aspects.
A trained team of physicians performed physical
examinations using standardized and zero-calibrated
instruments for measuring blood pressure(BP) [12]. BP
was measured, manually by a trained operator using a
mercury sphygmomanometer according to a standard
protocol, twice from each right and left arms in sitting
position after 5 minutes of rest. The first Korotkoff
sound was recorded as the systolic blood pressure (SBP)
and the disappearance of the sounds (V phase) was con-
sidered as the diastolic blood Pressure (DBP). The
values of hypertension used in analysis were recorded as
mean measured BP in higher arm [13].
The aims of our interventions are to improve the
knowledge, attitude and behaviors of general population,
hypertensive patients, their relatives and health profes-
sionals and to increase the chance of early detection,
treatment and control of hypertension by means of edu-
cation of health professionals (physicians, nurses and
health staff), patients and public about prevention, early
diagnosis, adherence to treatment and control of
hypertension.
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more than 140/90 mm Hg in non-diabetic patients and
equal or more than 130/80 mmHg in diabetic subjects
[12] or if the patient was taking antihypertensive medi-
cations. Participants, who had been previously diagnosed
to have hypertension, were considered to be aware of
their hypertension. Participants were considered to be
treated if they were taking antihypertensive drugs.
Hypertension was considered controlled if the patients
were receiving anti-hypertensive medications and their
average blood pressure was considered less than 140/90
mm Hg in non-diabetic patients or less than 130/80
mmHg in diabetic patients. Participants were considered
to have diabetes whether it had been diagnosed pre-
viously by a doctor or they had two separate fasting
blood glucose more than 125 mg/dl or 2 hour post-
prandial glucose more than 200 mg/dl or if they were
receiving anti-diabetic medications [13].
For quality control purposes, the whole IHHP have
been extremely evaluated with promising results [11].
Statistical analysis
Statistical analysis was performed using the SPSS statis-
tical package version 15.0 for Windows (SPSS Inc., Chi-
cago, USA). The significance level was set at P < 0.05.
The data are presented as frequencies, percentages and
95% confidence intervals. Prevalence of hypertension,
awareness, treatment, and control rates in interventional
and reference areas were compared by x² test. The pre-
valence of hypertension as well as the awareness, treat-
ment, and control rates were adjusted for age, sex and
BMI were compared with logistic regression test to cal-
culate the independent association between the above
variables and the prevalence, awareness, treatment and
control rates of hypertension.
Results
In this study, data on 10884 participants in interven-
tional counties (Isfahan and Najaf Abad) and 11192 in
reference city (Arak) were included in 2001 and 2007 as
a whole. The study population of the pre-intervention
survey included 6175 in the interventional area and
6339 in the reference area. The corresponding figure in
the post-intervention survey was 4717 (47.19% male) in
the interventional area and 4853 (50.7% male) indivi-
duals in the reference area.
Table 1 shows the age, sex, BMI, BP and diabetes sta-
tus of the population studied in 2001 and 2007. There
was no overall significant difference in mean age in
interventional and reference Table 2 demonstrates the
prevalence, awareness, treatment and control of hyper-
tension in interventional vs. reference areas in 2001 and
2007. The prevalence of hypertension in the interven-
tional areas had a non-significant decrease from 20.5%
in 2001 to 19.6% in 2007, whereas in the reference area,
it had a significant rise from 17.4% to 19.6% (P = 0.003)
respectively. If we consider blood pressure≥ 140/90 in
diabetic and non diabetic individuals for definition of
hypertension the prevalence of hypertension in the
interventional had no significant decrease from 18.9% in
2001 to 17.8 in 2007, whereas in the reference area, it
had a significant rise from 15.7% to 17.9%(p = 0.002).
Mean systolic blood pressure in study population
decreased significantly in interventional area (P < 0.001)
whereas in the reference population, this decline was
not significant (P = 0.24). Mean diastolic blood pressure
decreased in both interventional and reference areas but
this reduction was significant in reference area.
The awareness, treatment and control of hypertension
increased significantly in rural and urban areas of inter-
ventional countries (P < 0.001), the awareness and
Table 1 Characteristics of participants: IHHP program
Interventional area reference area
Before (N = 6175) After (N = 4719) P-value Before (N = 6339) After (N = 4853) P-value
Age year (mean±SD) 38.61 ± 14.72 38.54 ± 15.27 0.83 39.17 ± 15.12 39.03 ± 15.85 0.64
Sex Male 48.7% 49.3% 49.2% 50.7%
Female 51.3% 50.7% 0.51 50.8% 49.3% 0.12
BMI (kg/m
1) <25 45.7% 44.5% 53.1% 49.4%
25-<29.9 35.4% 37.0% 0.23 32.6% 34.9% 0.001
30 18.9% 18.5% 14.3% 15.6%
Diabetes mellitus 6.3% 7.1% 0.09 4.9% 6.5% <0.001
Prevalence of hypertension
base on DM(2)
20.5% 19.6% 0.24 17.4% 19.6% 0.003
Prevalence of hypertension(3) 18.9% 17.8% 0.14 15.7% 17.9% 0.002
Mean systolic blood pressure 116.13 ± 19.37 112.92 ± 18.27 <0.001 115.22 ± 18.96 114.79 ± 19.62 0.24
Mean diastolic blood pressure 74.79 ± 11.93 74.43 ± 11.06 0.11 76.18 ± 10.22 73.54 ± 11.03 <0.001
1) Body mass index (kg/m2).
2) BP ≥ 140/90 in nondiabetic BP ≥ 130/90 in diabetic patient.
3) BP ≥ 140/90 in diabetic & nondiabetic patient.
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(Table 2)
Table 3 shows that in interventional areas, the aware-
ness, treatment, and control rates of hypertension
increased significantly in the age groups of more than
40 years (P< 0.01). In the age group of 19-39 years old
no significant increase was seen in the awareness, treat-
ment, and control rates of hypertension. This table also
shows that the awareness, treatment and control rates of
hypertension had a more favorable improvement in
interventional than in reference area. These rates had
significant improvement in population aged ≥40 years in
interventional vs. reference areas too. Awareness, treat-
ment and control rates of hypertension increased signifi-
cantly in all groups of BMI in interventional area the
corresponding figures were not significant in the refer-
ence area.
Multiple logistic regression analysis revealed that after
adjustment for the residence area and the year of study,
the prevalence of hypertension in the age groups of 40
to 59 years and more than 60 years were 4.64 and 18.30
times more than the age group of 19 to 39 years. In
addition, the prevalence of hypertension was 1.98 and
3.14 times higher in overweight and obese individuals in
comparison with normal-weight participants. In the age
groups of 40 to 59 years and more than 60 years the
awareness about hypertension was 2.89 and 6.99 times
higher than in the age group of 19 to 39 years. Further-
more, overweight and obese individuals were 1.35 and
1.68 times more awarded of their high blood pressure
than normal weight population. Multiple logistic regres-
sion analysis revealed that the treatment of hypertension
in age groups of 40 to 59 years and more than 60 years
were 3.15 and 7.87 times higher than in the age group
of 19 to 39 years. In addition, treatment rates were 1.22
and 1.50 times higher in overweight and obese indivi-
duals than in normal weight participants. Hypertension
control was 1.46 and 2.26 times higher in the age
groups of 40 to 59 years and more than 60 years than
t h ea g eg r o u po f1 9t o3 9y e a r s .A l s oi ts h o w e dt h a tt h e
prevalence, awareness, treatment, and control rate of
hypertension in high school diploma patients were bet-
ter than lower educated patients. Overweight individuals
had the same control rate as normal weight individuals
but obese individuals had low control rate (0.86%) of
hypertension in comparison with normal weight indivi-
duals. The awareness, treatment and control rates of
hypertension were 2.22, 2.3, and 2.37 times more in
women compared to men and in educated population it
is 1.11, 1.18, and 1.61 times higher than non-educated
participant (Table 4).
Discussion
In this community trial, that to the best of our knowledge
is the first of its kind in developing countries, the inte-
grated and comprehensive interventions of this popula-
tion-based program resulted in favorable changes in the
prevalence, awareness, treatment and control of hyper-
tension. Although the decline in the prevalence of hyper-
tension was not significant in the intervention countries,
but by considering its significant increase in the reference
country while usual health care services were similarly
undergoing in both areas. It can be assumed that if speci-
fic interventional programs were not performed in inter-
ventional areas, the prevalence of hypertension would
have increased similar to the reference area. Moreover,
the mean systolic BP declined significantly in the inter-
vention population but not in the reference area.
Previous studies in the US have shown that the preva-
lence of hypertension to be 28.7%, with an increase of
3.7% from 1988 to 1991 Hypertension. The prevalence
of hypertension was highest in non-Hispanic blacks
(33.5%), increased with age (65.4% among those aged
≥60 years), and tended to be higher in women (30.1%)
[14]. In another study that was conducted in the US in
2003-2004 the overall prevalence was 29.3%. When
compared with 1999-2000, there was no significant
increase in the overall prevalence of hypertension [15].
A study in China revealed that the overall prevalence of
hypertension was 48.5% [7].
Table 2 Awareness, treatment and control rates of hypertension in interventional and reference area: IHHP, 2001-2007
Time Area Awareness Treatment Control
2001
N = 12514
2007
N = 9572
P-value 2001
N = 12514
2007
N = 9572
P-value 2001
N = 12514
2007
N = 9572
P-value
Interventional area Urban 404(41.6) 349(48) 0.009 341(35.2) 305(42.5) 0.002 77(7.9) 112(15.6) <0.001
Rural 107(36.5) 92(58.2) <0.001 100(34.2) 78(49.7) 0.001 12(4.1) 26(16.6) <0.001
Total 511(40.4) 441(49.8) <0.001 441(34.9) 383(43.8) <0.001 89(7.1) 138(15.8) <0.001
Reference
Area
Urban 314(44.1) 212(48.5) 0.15 267(37.5) 190(43.8) 0.035 78(11) 71(16.4) 0.009
Rural 143(37.1) 232(45.2) 0.015 121(31.5) 188(36.9) 0.096 29(7.6) 61(12) 0.031
Total 457(41.7) 444(46.7) 0.021 388(35.4) 378(40) 0.031 107(9.8) 132(14) 0.003
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morbidity and mortality rate in individuals with hyper-
tension [15]. Therefore, in the current study, 3.18
mmHg reductions in systolic BP in interventional areas
may result to a significant decline in the incidence of
heart failure, stroke, myocardial infarction and other
atherosclerotic events in the future [15]. The reason
behind this decline in interventional areas might be
increasing the awareness of population about hyperten-
sion and simultaneous education of health professionals
on the role of pharmacological and non pharmacological
treatment as well as how to treat patient with multiple
anti-hypertensive drugs and efforts to increase the
patients’ compliance. The synergetic and dose of inter-
ventional activities in such comprehensive program
might be effective as well.
While no change was observed in interventional areas,
a significant decrease was seen in mean diastolic pres-
sure in reference area. Changes in diastolic blood
pressure in the population’s studies are difficult to
explain, whereas we educated separate personnel in
interventional and reference area to measure diastolic
BP. it may be due to more difficult and less accurate
measurement of the diastolic blood pressure based on
Korotkoff sounds in the general population. Other
studies showed controversial changes in diastolic pressure
during different periods of the study [15,16].
Some studies showed Prevalence of diabetes in adults
worldwide was estimated to be 4.0% in 1995 and will
rise to 5.4% by the year 2025[15]. It is higher in devel-
oped countries than in developing ones. This increase is
probably due to population aging, urbanization, and
increase in the prevalence of obesity and physical inac-
tivity [16]. In our study the prevalence of diabetes melli-
tus showed a non significant uprising trend in
interventional area (from 6.3% to 7.1%) and significant
increase in reference area (from 4.9% to 6.5%). This
increase in control group was 2 times greater than the
Table 3 Awareness, treatment, and control of hypertension by age and body mass index in interventional and
reference areas: IHHP, 2001-2007
Percentage (%)
Age and BMI Interventional area Reference area
2001
N = 12514
2007
N = 9572
P-value 2001
N = 12514
2007
N = 9572
P-value
Awareness
Age, y
19-39 47(18.0) 43(24.4) 0.10 26(13.1) 39(20.9) 0.043
40-59 206(37.9) 183(48.8) 0.001 183(39.8) 140(41.7) 0.59
≥60 258(56.2) 215(64.4) 0.021 248(56.5) 265(62.1) 0.095
BMI, kg/m2
<25 93(29.2) 76(41.1) 0.007 146(38.3) 138(43.0) 0.209
25-29.9 216(40.8) 192(49.2) 0.011 180(41.8) 191(47.9) 0.077
≥30 192(48.6) 163(56.2) 0.049 130(45.9) 111(49.8) 0.39
Treatment
Age, y
19-39 33(12.7) 29(16.6) 0.26 19(9.6) 34(18.2) 0.015
40-59 173(31.8) 154(42.0) 0.002 151(32.9) 115(34.3) 0.67
≥60 235(51.3) 200(60.2) 0.013 218(49.7) 229(54.3) 0.18
BMI, kg/m2
<25 87(27.4) 70(37.8) 0.014 125(32.9) 118(36.9) 0.27
25-29.9 188(35.6) 161(42.1) 0.045 148(34.3) 160(40.4) 0.071
≥30 156(39.5) 142(49.5) 0.009 114(40.3) 96(43.4) 0.48
Control (all treated)
Age, y
19-39 13(5.0) 16(9.1) 0.089 11(5.6) 21(11.2) 0.044
40-59 30(5.5) 56(15.3) <0.001 42(9.2) 44(13.1) 0.078
≥60 46(10.0) 66(19.9) <0.001 54(12.3) 67(15.9) 0.13
BMI, kg/m2
<25 20(6.3) 24(13.0) 0.011 41(10.8) 47(14.7) 0.12
25-29.9 43(8.1) 63(16.5) <0.001 42(9.8) 54(13.6) 0.083
≥30 24(6.1) 46(16.0) <0.001 24(8.5) 31(14.0) 0.048
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m a yh a v es l o w e dd o w nt h er a p i du p r i s i n gt r e n do f
diabetes in interventional areas.
Using BP ≥140/90 mm Hg as a cut-off level in hyper-
tensive people with diabetes might underestimate the
prevalence of hypertension. In our study the prevalence
of diabetes in general population was up to 6.3%, (table
1) so we defined hypertension in diabetic patients equal
or more than 130/80 to attain a more accurate preva-
lence rate [12]. Additionally, studies using a BP goal of
<140/90 mm Hg in hypertensive people with diabetes
might overestimate BP control rates [17]. Therefore, in
this study consistent with a previous study [17], different
control goals (<130/80 mm Hg) were used for those
with diabetes to provide a more accurate control rate.
Two surveys in England and Canada documented that
many individuals with hypertension are unaware of their
disease (63% and 42% respectively), and those who are
awared are often untreated (19%) or under-treated (23%)
[18,19]. In this study the improvement in awareness, treat-
ment and control rates of hypertension in rural and urban
areas of interventional areas were the same, both better
than reference area. (9.7 vs. 5.1, 8.7 vs. 4.8 and 8.7 vs. 4.4
respectively)(Table 2). This improvement may lead to
decrease future cardiovascular events in our country.
Evaluation of the increase in awareness, treatment and
control of hypertension ind i f f e r e n ta g eg r o u p sw a s
another important way for assessing the efficacy and
conduction of interventional programs and may need
more aggressive intervention in low compliance age
groups. The current study demonstrates that since 2001,
awareness, treatment and control rates of hypertension
in patients who are older than 40 years in interventional
areas increased significantly (table 3) and this might be
due to their greater concern about their health status or
less effectiveness of interventional activities in younger
people. In spite of non-significant rise in awareness,
treatment and control of hypertension in younger
patients we had a favorable trend in this group;
therefore more specific programs may be needed for
this age group in the future. Furthermore, previous
studies such as NHANES study showed that, compared
with younger individuals with hypertension, older indivi-
duals with hypertension have a lower control rate despite
being equally likely to be treated[20-22]. Other study
reported that the awareness and control rates of hyper-
tension were better in older people, whereas there was a
relatively under-treatment for the case of hypertensive
people of younger age [14]. In our study awareness, treat-
ment and control rates of hypertension improved signifi-
cantly in normal weight, over weight and obese patients;
in interventional area the corresponding figures were not
significant in the reference area.
In our study, in all participants (interventional and
reference areas) the number of hypertensive patients
with optimal weight (BMI< 25 kg/m
2) decreased but in
the reference area the prevalence of over-weight and
obesity increased from 2001 to 2007 compared to inter-
ventional area. This might be the result of the effects of
interventional activities in interventional areas. This dif-
ference in shifting BMI in interventional and reference
areas may be the important reason for lesser increase in
the prevalence of diabetes and hypertension in interven-
tional areas in comparison with the reference area.
Our study showed more favorable improvement in the
Awareness of Hypertension in patients living in interven-
tional than in reference area. As well as better improvement
in the treatment rate of hypertension in the overweight and
Control rate in the obese hypertensive patients in interven-
tional area compared with reference area.
Many studies showed significant positive correlation
between BMI and systolic or diastolic BP in the whole
population [23-25]. In our study, the prevalence of
hypertension increased by rising BMI in general popula-
tion in both intervention and reference counties. Obese
individuals have approximately 3 times more chance to
be hypertensive than those with optimal weight patients
furthermore the awareness and treatment rates in obese
Table 4 Multiple logistic regressions of prevalence, awareness, treatment and control of hypertension in the
interventional and reference areas: IHHP, 2001-2007
Predictors prevalence Awareness Treatment Control
Age (reference: 19-39 y) R R R R
40-59 y 4.64(4.22-5.1) 2.89(2.35-3.56) 3.15(2.51-3.97) 1.46(1.06-2.01)
≥60 y 18.30(16.37-20.46) 6.99(5.62 - 8.69) 7.87 (6.21-9.98) 2.26(1.64-3.11)
Sex (reference: man)
Woman
0.995(0.92-1.08) 2.22 (1.93-2.55) 2.298(1.99-2.65) 2.37(1.89-2.96)
High school diploma 0.69(0.63 - 0.77) 1.11(0.91-1.37) 1.18(0.95-1.46) 1.61(1.19-2.18)
BMI (reference : <25 kg/m
2)R R R R
Overweight, 25-29.9 kg/m
2 1.98(1.80-2.17) 1.35(1.15-1.59) 1.22(1.03-1.45) 1.01(0.798-1.29)
Obese, ≥30 kg/m
2 3.14(2.82-3.50) 1.68(1.397-2.01) 1.497(1.24-1.80) 0.86(0.66-1.13)
Adjusted for years and residency (intervention area and reference area).
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the over weight and obese patients could not control
their hypertension as well as normal weight participant
(table 4). This might be due to poor compliance of
obese patients in pharmacological and non-pharmacolo-
gical treatment.
In the National Health Interview Survey, 38% of
women 65 to 74 years old reported hypertension com-
pared with 31% of men in the same age group [17].
Hajjar and colleagues showed that men experienced
more hypertension than women (18.1% vs. 10.1%) [14].
In our study the prevalence of hypertension was not sig-
nificantly different in terms of gender, this finding is
contrary to some other surveys in which the prevalence
of hypertension has been generally higher among males
than females [13]. In our study, awareness, treatment
and control of hypertension in women were approxi-
mately 2 times greater than men and this indicated that
women had more concerns about their self-care. Also
our study like other study showed that the prevalence,
awareness, treatment, and control rate of hypertension
in educated patients is better (table 4). The main goals
of interventional activities in this study were life-style
modification and increasing the awareness of the com-
munity for better detection of hypertension and encour-
agement of hypertensive patients and their families to
improve their knowledge attitudes and behaviors toward
treatment and control of their diseases. Education of
health professionals toward the importance of pharma-
cological and non-pharmacological treatments of hyper-
tension was another objective.
Conclusion
In general the activities of this community trial helped
in improving hypertension prevalence, awareness, treat-
ment and control which may lead to decrease in cardio-
vascular complications in the future. Iran has one of the
youngest populations worldwide; therefore we need
more efforts to prevent hypertension from early life to
improve the control rate of hypertension in young
people in order to reduce burden of cardiovascular
events in the future. The findings of this large sample
size, quality controlled and comprehensive integrated
interventions of IHHP can be generalized to other
developing countries; however further steps need to be
taken to evaluate the effects of these interventional
activities on late-onset complications of hypertension.
Additional material
Additional file 1: Appendix 1. Specific interventional strategies for high
blood pressure prevention and control in the Isfahan Healthy Heart
Program.
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